期刊文献+

胺碘酮治疗急性心肌梗死伴快速房颤临床观察

下载PDF
导出
摘要 目的 观察胺碘酮治疗急性心肌梗死伴快速房颤的疗效。方法 35例患者在常规治疗的基础上、心电监护下,先给予胺碘酮150mg(或3mg/kg)缓慢静脉注射,然后静脉滴注维持,滴速0.5—1mg/min。结果 35例病人用药后23例转为窦性心律占65.7%,9例未能转为窦性心律但心室率下降至满意范围,心功能改善,占25.7%,无效3例,占8.6%,总效率为91.4%。结论 胺碘酮治疗急性心肌梗死伴快速房颤,疗效可靠,安全度高。
作者 张壮丽
出处 《中原医刊》 2008年第6期74-75,共2页 Central Plains Medical Journal
  • 相关文献

参考文献4

二级参考文献12

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1398
  • 2Furberg CD, Psaty BM, Manolio TA, et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)[J]. Am J Cardiol, 1994, 74:236 -241.
  • 3Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study [J]. Am J Med, 1995, 98:476- 484.
  • 4Pstay BM, Manolio TA, Kuller LH, et al. Incidence of and risk factors for atrial fibrillation in older adults [J]. Circulation,1997, 96:2455-2461.
  • 5Kannel WB, Wolf PA. Benjamin EJ, et al. Prevalenc, incidence, prognosis, and predisposing conditions for atrial fibrillation: population - based estimates [J]. Am J Cardiol, 1998,82: 2N -9N.
  • 6Levy D, Vasan RS, D'Agostino RB, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study[J]. Circulation, 2004, 110:1042-1046.
  • 7Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study [J]. Am J Med, 1995, 98 (5) :476 - 484.
  • 8Friberg J, Scharling H, Gadsboll N, et al. Sex - specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study) [J]. Am J Cardiol, 2003, 92:1419 -1423.
  • 9Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea [J]. Circulation,2004, 110: 364-367.
  • 10Mestroni L. Genomic medicine and atrial fibrillfion [J]. J Am Coll Cardiol, 2003, 41:2193-2196.

共引文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部